Honor Recognizes Humacyte’s Progress in Accelerating the Manufacturing Platform and Process for Producing Vascular Conduits for Hemodialysis and Vascular Trauma Business Wire DURHAM, N.C. -- April 8, 2019 Humacyte, an innovator in biotechnology and regenerative medicine, received the Medical...
RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Humacyte , an innovator in biotechnology and regenerative medicine, announced publication in the medical journal Science Translational Medicine, of pivotal scientific work demonstrating Humacyte’s human acellular vessels (HAVs) repopulate with the...
RESEARCH TRIANGLE PARK, N.C. – January 7, 2019. Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 37th Annual J.P....
